XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Capital Stock Repurchase Plan Transactions
9 Months Ended
Sep. 30, 2025
Capital Stock Repurchase Plan Transactions [Abstract]  
Capital Stock Repurchase Plan Transactions 15.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

Three months ended September 30,

Nine months ended September 30,

2025

2024

2025

2024

Total cost of repurchased shares (in thousands)

$

180,776 

$

57,820 

$

253,477 

$

145,933 

Shares repurchased

407,500 

100,000 

532,500 

250,000 

Weighted average price per share

$

443.62 

$

578.21 

$

476.02 

$

583.73 

In November 2024, the Board of Directors authorized $300.0 million for additional stock repurchase under Chemed’s existing share repurchase program, and on August 1, 2025 the Board of Directors authorized an additional $300.0 million for additional stock repurchase. We currently have $301.8 million of authorization remaining under this share repurchase plan.